| Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial S Sundar, PK Sinha, M Rai, DK Verma, K Nawin, S Alam, J Chakravarty, ... The Lancet 377 (9764), 477-486, 2011 | 382 | 2011 |
| Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani B Purkait, A Kumar, N Nandi, AH Sardar, S Das, S Kumar, K Pandey, ... Antimicrobial agents and chemotherapy 56 (2), 1031-1041, 2012 | 338 | 2012 |
| Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis SK Bhattacharya, PK Sinha, S Sundar, CP Thakur, TK Jha, K Pandey, ... The Journal of infectious diseases 196 (4), 591-598, 2007 | 317 | 2007 |
| Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus R Kumar, M Nayak, GC Sahoo, K Pandey, MC Sarkar, Y Ansari, VNR Das, ... Journal of Infection and Chemotherapy 25 (5), 325-329, 2019 | 172 | 2019 |
| A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India TK Jha, S Sundar, CP Thakur, JM Felton, AJ Sabin, J Horton The American journal of tropical medicine and hygiene 73 (6), 1005-1011, 2005 | 171 | 2005 |
| SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021 MV Murhekar, T Bhatnagar, JWV Thangaraj, V Saravanakumar, ... International Journal of Infectious Diseases 108, 145-155, 2021 | 135 | 2021 |
| Diagnosis & management of leishmania/HIV co-infection PK Sinha, K Pandey, SK Bhattacharya Indian Journal of Medical Research 121 (4), 407, 2005 | 127 | 2005 |
| Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India PK Sinha, P Roddy, PP Palma, A Kociejowski, MAN Lima, VNR Das, ... The American journal of tropical medicine and hygiene 83 (2), 357, 2010 | 117* | 2010 |
| Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection J Mookerjee Basu, A Mookerjee, R Banerjee, M Saha, S Singh, K Naskar, ... Antimicrobial agents and chemotherapy 52 (3), 1080-1093, 2008 | 112 | 2008 |
| Asymptomatic infection with visceral leishmaniasis in a disease-endemic area in Bihar, India RK Topno, VNR Das, A Ranjan, K Pandey, D Singh, N Kumar, ... The American journal of tropical medicine and hygiene 83 (3), 502, 2010 | 111 | 2010 |
| Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India VP Singh, A Ranjan, RK Topno, RB Verma, NA Siddique, VN Ravidas, ... The American journal of tropical medicine and hygiene 82 (1), 9, 2010 | 102 | 2010 |
| Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India PK Sinha, J van Griensven, K Pandey, N Kumar, N Verma, R Mahajan, ... Clinical Infectious Diseases 53 (7), e91-e98, 2011 | 100 | 2011 |
| Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani R Kumar, GC Sahoo, K Pandey, VNR Das, P Das Drug delivery 22 (3), 383-388, 2015 | 85 | 2015 |
| Combination treatment for visceral leishmaniasis patients coinfected with human immunodeficiency virus in India R Mahajan, P Das, P Isaakidis, T Sunyoto, KD Sagili, MA Lima, G Mitra, ... Clinical Infectious Diseases 61 (8), 1255-1262, 2015 | 76 | 2015 |
| Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. VN Das, A Ranjan, S Bimal, NA Siddique, K Pandey, N Kumar, N Verma, ... The National Medical Journal of India 18 (3), 131-133, 2005 | 73 | 2005 |
| Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani P Bhattacharya, S Ghosh, SA Ejazi, M Rahaman, K Pandey, VN Ravi Das, ... PLoS Neglected Tropical Diseases 10 (2), e0004422, 2016 | 72 | 2016 |
| Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome) S Burza, R Mahajan, PK Sinha, J van Griensven, K Pandey, MA Lima, ... PLoS neglected tropical diseases 8 (8), e3053, 2014 | 71 | 2014 |
| Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T … MR Dikhit, A Kumar, S Das, B Dehury, AK Rout, F Jamal, GC Sahoo, ... Frontiers in immunology 8, 1763, 2017 | 68 | 2017 |
| Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes VNR Das, NA Siddiqui, RB Verma, RK Topno, D Singh, S Das, A Ranjan, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 105 (11 …, 2011 | 67 | 2011 |
| The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot study FF Naini, AV Shooshtari, B Ebrahimi, R Molaei Journal of Research in Pharmacy Practice 1 (2), 77-80, 2012 | 64* | 2012 |
